European Commission Approves First Tocilizumab Biosimilar
The biosimilar, commercially called Tyenne, is indicated to treat several autoimmune diseases as well as cytokine release syndrome and COVID-19.
Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The biosimilar, commercially called Tyenne, is indicated to treat several autoimmune diseases as well as cytokine release syndrome and COVID-19.
Numerous unresolved questions surround PPF treatment and support.
To date, the study is the largest to explore the relationship between severe psoriasis and coronary microvascular dysfunction.
The incidence of nonsevere extraarticular manifestations of RA decreased over time, likely because of a reduced incidence of rheumatoid nodules.
A recent Scientific Reports study investigated the effect of yoga on rheumatoid arthritis (RA) severity.